The adhesion ability and adaptability of bacteria, coupled with constant use of the same bactericides, have made the increase in the diversity of treatments against infections necessary. Nanotechnology has played an important role in the search for new ways to prevent and treat infections, including the use of metallic nanoparticles with antibacterial properties. In this study, we worked on the design of a composite of silver nanoparticles (AgNPS) embedded in poly-epsilon-caprolactone nanofibers and evaluated its antimicrobial properties against various Gram-positive and Gram-negative microorganisms associated with drug-resistant infections. Polycaprolactone-silver composites (PCL-AgNPs) were prepared in two steps. The first step consisted in the reduction in situ of Ag⁺ions using N,N-dimethylformamide (DMF) in tetrahydrofuran (THF) solution, and the second step involved the simple addition of polycaprolactone before electrospinning process. Antibacterial activity of PCL-AgNPs nanofibers againstE. coli,S. mutans,K. pneumoniae,S. aureus,P. aeruginosa, andB. subtiliswas evaluated. Results showed sensibility ofE. coli,K. pneumoniae,S. aureus, andP. aeruginosa, but not forB. subtilisandS. mutans. This antimicrobial activity of PCL-AgNPs showed significant positive correlations associated with the dose-dependent effect. The antibacterial property of the PCL/Ag nanofibers might have high potential medical applications in drug-resistant infections.

White spot lesions (WSLs) are very frequent alterations during orthodontic treatments causing demineralization of the dental enamel. Various dental treatments have been developed to prevent WSLs; the prevalence and incidence of these lesions remain significantly high. Although silver nanoparticles (AgNPs) have demonstrated good inhibitory effects against several microorganisms, more studies about antiadherence activity on different orthodontic appliance surfaces are necessary. To determine the inhibitory effect and antiadherence activity of AgNPs on the adhesion of S. mutans on surfaces of brackets and wires for orthodontic therapies, two sizes of AgNPs were prepared and characterized. The evaluation of S. mutans adhesion was performed with microbiological assays on surfaces of brackets and orthodontic modules in triplicate. Topographic characteristics of orthodontic brackets and wires were made by scanning electron and atomic force microscopies. All AgNP samples inhibited S. mutans adhesion; however, the smaller AgNPs had better inhibition than the larger ones. The presence of the module influenced the adhesion of S. mutans but not in the activity of AgNPs. The AgNPs used in this study showed to have good antimicrobial and antiadherence properties against S. mutans bacteria determining its high potential use for the control of WSLs in orthodontic treatments.

The main microorganism associated with the failure of endodontic treatments is Enterococcus faecalis. Although several endodontic therapeutics have demonstrated antimicrobial activity against E. faecalis, the antimicrobial effectiveness of chitosan (CsNPs) and silver nanoparticles (AgNPs) included into conventional endodontic sealers for endodontic therapies is still unclear. The objective of this study was to evaluate the antibacterial activity increment (AAI) of endodontic sealers containing CsNPs and AgNPs as well as some chemical components against E. faecalis by direct contact assays. CsNPs and AgNPs were synthesized by reduction and ionic gelation methods, respectively. Nanoparticles were characterized by dynamic light scattering and energy dispersive X-ray analysis. The bactericidal activity was tested on monolayers on agar plates and collagen membrane surface assays against E. faecalis. The size of CsNPs was 70.6±14.8 nm and zeta potential was 52.0±5.4 mV; the size of AgNPs was 54.2±8.5 nm, and zeta potential was –48.4±6.9 mV. All materials, single or combined, showed an AAI, especially when CsNPs, chlorhexidine (Chx), and the combination of CsNPs-Chx were added. However, the combination of CsNPs-Chx showed the highest (55%) AAI, followed by Chx (35.5%) and CsNPs (11.1%), respectively. There was a significant statistical difference in all comparisons (p < 0.05). Tubliseal (40%) and AH Plus (32%) sealants showed a higher AAI on E. faecalis in the monolayer test and collagen membrane assay analyzed by scanning electron microscopy. Tubliseal and AH plus sealers combined with nanoparticles, especially CsNPs-Chx, could be used for conventional endodontic treatments in the control of E. faecalis bacteria.